| ABCA1 heterozygous | ABC1 (2) | 2 |
| Abetalipoproteinemia | MTP (2) | 2 |
| Acromesomelic dysplasia | NPR2 (1) | 1 |
| Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) | | 1 |
| Adrenoleukodystrophy (ALD) | | 1 |
| Adult-onset Still’s disease (AOSD) | | 1 |
| Age-related macular degeneration (AMD) | | 121 |
| Aicardi syndrome | | 1 |
| Alexander disease | GFAP (3) | 6 |
| Allergic granulomatous angiitis | | 1 |
| Alzheimer's disease (AD) | APOE (10), APOE4 (3), APP (4), C9ORF (1), CD33 (2), MAPT (2), PSEN1 (14), PSEN2 (1), TBK1 (1), TREM2 (3) | 180 (Available Differentiated cells) |
| Alzheimer's disease (AD) (Gene-edited) | APP (6), PSEN1 (8) | 14 |
| Alzheimer's disease (AD) (familial) | APP (3), APPV7171 (4), PSEN1 (1), PSEN2 (1) | 11 |
| Amyotrophic lateral sclerosis (ALS) | ASYMPTOMATIC C9ORF72 CARRIER (1), C9ORF72 (46), FIG4 (1), FUS (3), SETX (1), SETX, SOD1 (1), SOD1 (36), SOD1 > D90A (1), TARDBP (5), VCP (1) | 532 |
| Anemia (phenotype) | | 1 |
| Angelman syndrome | UBE3A (2) | 10 |
| Aplastic anemia | | 3 |
| Arrhythmogenic right ventricular cardiomyopathy | | 2 |
| Arteriolosclerosis | | 2 |
| Associated pulmonary arterial hypertension | | 18 |
| Ataxia-telangiectasia | | 3 |
| Atrial fibrillation | | 14 |
| Atrial tachycardia | | 1 |
| Autism spectrum disorder (ASD) | | 110 (Available Differentiated cells) |
| Autoimmune hemolytic anemia (AHA) / Idiopathic warm (AHA) | | 1 |
| Bardet-biedl syndrome | | 22 |
| Batten disease (cln3) | CLN3 (23) | 23 |
| Batten disease (cln6) | | 8 |
| Behçet’s disease | | 2 |
| Beta thalassemia | HBB (2) | 2 |
| Bethlem myopathy | | 2 |
| Bilateral frontoparietal polymicrogyria | GPR56 (1) | 1 |
| Bipolar disorder | | 30 |
| Blinding eye disease | | 18 |
| Borderline NASH (fatty liver disease) | | 2 |
| Breast cancer | BRCA1 (3) | 3 |
| Brugada syndrome | | 6 |
| Buerger’s disease | | 1 |
| Cardiomyopathy | | 48 |
| Carpal tunnel syndrome | | 18 |
| Catecholaminergic polymorphic ventricular tachycardia | RYR2 (2) | 2 |
| Ccanavan Disease | ASPA (1) | 1 |
| Cchoroideremia (CHM) | CHM (1), NGLY1 (1) | 4 |
| Cerebral creatine deficiency syndrome 1 (CCDS1) | SLC6A8 (1) | 1 |
| Cerebral palsy (CP) | | 19 |
| Cerebrovascular disease | | 4 |
| Ceroid lipofuscinosis | CHM (1), CLN2 (1) | 2 |
| Charcot-Marie-Tooth disease | FIG4 (1), MFN2 (10), MPZ (2), PMP22 (7), VCP (1) | 22 |
| Chromosome 16p11.2 deletion syndrome | | 5 |
| Chronic inflammatory demyelinating polyneuropathy (CIDP) | | 2 |
| Chronic myeloid leukemia | | 1 |
| Congenital disorder of deglycosylation (CDDG) | CFTR (1) | 1 |
| Congenital heart block | | 2 |
| Congenital ichthyosis / Ichthyosis syndrome | | 1 |
| Congenital insensitivity to pain with anhidrosis (CIPA) | | 2 |
| Congenital myasthenic syndrome | GFPT1 (1) | 7 |
| Congenital myopathy | MTM11 (1) | 1 |
| Control | C9ORF72 (5), CCR5 (1), GFAP CORRECTED (2), HBB (1), HD (5), HNF1A (1), MECP2 (2), NGN2 (2), SNCA (1), SOD1 > D90A CORRECTED (1), TAF1 VARIANT CORRECTED (4) | 25 |
| Coronary artery disease | | 43 |
| Corticobasal degeneration (CBD） | | 1 |
| Crohn's disease | | 3 |
| Crow‐Fukase syndrome | | 2 |
| Cystic Fibrosis (CF) | DMPK (1) | 1 |
| Cystinosis | | 1 |
| DMD | DMD (5) | 5 |
| DMRV / GNE myopathy | | 2 |
| Danon disease | | 1 |
| Definite NASH (fatty liver disease) | | 32 |
| Diabetes | HNF1A (2) | 3 |
| Diabetes mellitus | | 60 |
| Diabetes mellitus type II | | 12 |
| Diabetes type I | | 21 |
| Diabetes type II | | 95 |
| Diabetes type unknown | | 4 |
| Diabetic retinopathy (DR) | | 32 |
| Diamond-Blackfan anemia | | 1 |
| Dilated cardiomyopathy (DCM) | | 303 |
| Distal Myopathy | | 3 |
| Down syndrome | 47,XX,+21 (4), 47,XY,+21 (3) | 8 |
| Dravet syndrome | SCN1A (11) | 11 |
| Drug-induced liver injury (DILI) | | 4 |
| Duchenne Muscular dystrophy (DMD) | DMD (1) | 2 |
| Dystrophia myotonica 1 (DM1) | DMPK (1) | 1 |
| Ehlers-Danlos syndrome | COL3A1 (1) | 2 |
| Eosinophilic granulomatosis with polyangiitis (EGPA) | | 1 |
| Eosinophilic sinusitis | | 1 |
| Epidermolysis bullosa | | 1 |
| Epilepsy | ALG13 (1), GABRA1 (1), KCNC1 (1), PCDH19 (2), SCN2A (1) | 57 (Available Differentiated cells) |
| Fabry disease | | 3 |
| Facioscapulohumeral muscular dystrophy 1 (FSHD1) | LRIF1 (1) | 6 |
| Familial Mediterranean fever | | 1 |
| Fatty liver disease - steatosis (not NASH) | | 2 |
| Focal cortical dysplasia (FCD) | | 2 |
| Focal segmental glomerulosclerosis | | 20 |
| Fragile X syndrome | FMR1 (4) | 4 |
| Friedreich ataxia 1 (FRDA) | FXN (2) | 2 |
| Frontotemporal degeneration | C9ORF72 (4), GRN (4), MAPT (10), PGRN (2), VCP (1) | 25 |
| Frontotemporal dementia (FTD) | C9ORF72 (6), MAPT (15) | 30 |
| Frontotemporal lobar degeneration (FTLD) | | 2 |
| GM1-gangliosidosis | | 1 |
| Galactosialidosis | | 1 |
| Gaucher disease | GBA (1) | 2 |
| Giant cell arteritis (GCA) | | 2 |
| Glaucoma | | 20 |
| Glut1 deficiency syndrome 1 (Glut1DS1) | SLC2A1 (1) | 1 |
| Glycogen storage disease / GSD type V (muscle glycogen phosphorylase deficiency) | | 1 |
| Glycosylphosphatidylinositol(GPI) anchor deficiency | | 3 |
| Granulomatosis with polyangiitis (GPA) | | 1 |
| Hemiconvulsion-hemiplegia-epilepsy syndrome | | 2 |
| Hemimegalencephaly | | 1 |
| Hepatitis C (HCV) | | 91 |
| Hereditary dystonia | | 1 |
| Homozygous familial hypercholesterolemia | LDLR (6) | 6 |
| Hunter syndrome | | 2 |
| Huntington's disease (HD) | HD (14), HTT (36), IT15 (1), SMN1 (1) | 58 |
| Hurler syndrome | IDUA (1) | 1 |
| Hutchinson-gilford progeria syndrome (HGPS) | | 2 |
| Hyperalphalipoproteinemia | SR-BI (2) | 2 |
| Hypertrophic cardiomyopathy | TNNT2 (1) | 83 |
| Idiopathic aplastic anemia | | 1 |
| Idiopathic pulmonary arterial hypertension | | 16 |
| Idiopathic pulmonary fibrosis (IPF) | | 182 |
| Idiopathic thrombocytopenic purpura | | 1 |
| IgG4-related disease | | 1 |
| IgG4-related thyroid disease | | 1 |
| Inappropriate sinus tachycardia | | 1 |
| Infantile neuroaxonal dystrophy (INAD) | PLA2G6 (5) | 5 |
| Intellectual disability (ID) | | 60 |
| Interstitial lung disease | | 1 |
| Isaacs syndrome | | 1 |
| Isogenic control | | 3 |
| Kearns-sayre syndrome (KSS) | | 1 |
| Keratoconus | | 2 |
| Krabbe disease | GALC (1) | 1 |
| Landau-Kleffner syndrome | | 1 |
| Left ventricular hypertrophy | | 15 |
| Left ventricular non-compaction cardiomyopathy | | 10 |
| Lennox-Gastaut syndrome (LGS) | | 2 |
| Lesch-nyhan syndrome (LNS) | HPRT1 (1) | 1 |
| Lewy body dementia | | 8 |
| Lewy body dementia (LBD) | | 1 |
| Limb-girdle muscular dystrophy | DYSF (5) | 5 |
| Limb-girdle muscular dystrophy (LGMD2b) | DYSF (15) | 15 |
| Lissencephaly | DCX (1) | 1 |
| Long QT syndrome | | 3 |
| Long QT syndrome (familial) | | 13 |
| Long QT syndrome 1 (LQT1) | | 3 |
| Long QT syndrome 2 (LQT2) | KCNH2 (1) | 1 |
| Long QT syndrome 3 (LQT3) | SCN5A (1) | 1 |
| MELAS | | 1 |
| Malignant rheumatoid arthritis (MRA) | | 1 |
| Mental illness | DISC1 EXON 8 WILD-TYPE (2) | 2 |
| Mental retardation | CHAMP1 (2), SYNGAP1 (1) | 3 |
| Mesial temporal lobe epilepsy with hippocampal sclerosis | | 2 |
| Microscopic polyangiitis (MPA) | | 1 |
| Migraine disorder | MAJOR CHR17 AMPLIFCATION; MINOR CHR7 DELETION (1) | 28 |
| Mild left ventricular hypertrophy | | 1 |
| Miller-dieker lissencephaly syndrome (MDLS) | | 1 |
| Mitochondrial diseases | | 1 |
| Mixed Connective-Tissue Disease (MCTD) | | 1 |
| Monogenic diabetes | | 13 |
| Mortor dominant | | 1 |
| Moyamoya disease | | 3 |
| Mucopolysaccharidosis (MPS) | SGSH (1) | 3 |
| Multifocal motor neuropathy (MMN) | | 1 |
| Multiple sclerosis (MS) | | 4 |
| Multiple system atrophy (MSA) | | 6 |
| Muro disease (Kii ALS/PDC) | | 3 |
| Muscular dystrophy | DMD (5), LAMA2 (1), POMT2 (1) | 9 |
| Myasthenia Gravis (MG) | | 1 |
| Myocardial infarction | | 18 |
| Myoclonic epilepsy | CHD2 (1) | 1 |
| Myotonic dystrophy | CNBP (4), DMPK (1) | 9 |
| Nescav syndrome | KIF1A (5) | 6 |
| Neurodegeneration with brain iron accumulation 5 (NBIA5) | WDR45 (1) | 1 |
| Neurodevelopmental disorder | DHPS (1) | 1 |
| Neuroferritinopathy | | 1 |
| Neurofibromatosis type1 (NF1) | | 1 |
| Neurofibromatosis type2 (NF2) | | 1 |
| Neuromyelitis Optica | | 4 |
| Neuromyelitis Optica Spectrum Disorders (NMOSD) | | 1 |
| Neuronal migration disorder | PIK3R2 (1) | 3 |
| Neuropathy | GARS (2), SCN9A (6) | 39 |
| Niemann-pick disease | NPC1 (1), SMPD1 (3) | 5 |
| Non-als motor neurone disease | | 1 |
| Ohtahara syndrome | STXBP1 (1) | 1 |
| Ornithine transcarbamylase deficiency (OTCD) | | 1 |
| Osteogenesis imperfecta type iv (OI4) | COL1A2 (1) | 1 |
| PACS1 (Schuurs-Hoeijmakers) syndrome | PACS1 (2) | 2 |
| Pain agnosia | SCN11A (2) | 2 |
| Parkinsonism | GBA (2), LRRK2 (6), MAPT (1), PARK2 (4), PINK1 (1), SNCA (3) | 26 |
| Parkinson’s disease (PD) | GBA (18), LRRK2 (8), SNCA (9) | 99 |
| Paroxysmal nocturnal hemoglobinuria (PNH) | | 1 |
| Pemphigoid (including epidermolysis bullosa acquisita) | | 2 |
| Pemphigus | | 2 |
| Periodic paralysis | | 1 |
| Phenylketonuria | PAH PAH (1) | 2 |
| Pick's disease | | 1 |
| Pitt-hopkins syndrome (PTHS) | TCF4 (1) | 1 |
| Polyarteritis nodosa (PAN) | | 2 |
| Polymicrogyria | | 1 |
| Pompe’s disease (adult type) | | 1 |
| Primary antiphospholipid syndrome | | 2 |
| Primary erythromelalgia | SCN9A (2) | 4 |
| Primary immunodeficiency syndrome | | 3 |
| Primary lateral sclerosis (PLS) | | 7 |
| Primary open angle (POAG) | | 20 |
| Primary progressive aphasia (PPA) | | 1 |
| Progressive multifocal leukoencephalopathy (PML) | | 1 |
| Progressive supranuclea palsy (PSP) | | 1 |
| Prolonged QT interval | | 6 |
| Pulmonary arterial hypertension | ALK1 (2), BMPR2 (4) | 6 |
| Pulmonary atresia | | 1 |
| Pustular psoriasis | | 1 |
| Pyogenic sterile arthritis / Pyoderma gangrenosum and acne syndrome | | 1 |
| Rasmussen encephalitis | | 2 |
| Relapsing polychondritis (RP) | | 1 |
| Resolved systolic anterior motion | | 1 |
| Restrictive cardiomyopathy | | 1 |
| Retinitis pigmentosa | | 5 |
| Rett syndrome | FOXG1 (5), MECP2 (6), SHANK3 (1) | 15 |
| Right ventricular outflow tract premature ventricular contractions | | 2 |
| Ring chromosome 20 syndrome | | 2 |
| Sanfilippo syndrome / MPS IIIC (acetyl-CoA:heparan-α-Ｄ-glucosaminide N-acetyltransferase deficiency) | | 1 |
| Schizophrenia | | 4 |
| Semantic Dementia | | 2 |
| Severe combined immunodeficiency | ADA (2) | 2 |
| Sickle cell anemia | HBB (55) | 55 |
| Sjögren’s syndrome | | 1 |
| Skeletal displasia | | 4 |
| Small atrial septal defect | | 1 |
| Smith-magenis syndrome (SMS) | | 1 |
| Spinal muscular atrophy | SMN1 (14) | 18 |
| Spinal-Bulbar Muscular Atrophy (SBMA) | | 10 |
| Spinocerebellar Degeneration | | 14 |
| Spinocerebellar ataxia type 1 | | 2 |
| Spinocerebellar ataxia type 3 | ATXN3 (4) | 4 |
| Spondylometaphyseal displasia | | 2 |
| Stevens-Johnson syndrome (SJS) | | 1 |
| Sturge-Weber syndrome | | 1 |
| Subacute sclerosing panencephalitis (SSPE) | | 2 |
| Syringomyelia | | 1 |
| Systemic amyloidosis | | 2 |
| TNF receptor-associated periodic syndrome | | 1 |
| Takayasu arteritis | | 3 |
| Tangier disease | ABC1 (2), ABCA1 (4) | 6 |
| Tay-sachs disease (TSD) | HEXA (1) | 1 |
| Thrombotic thrombocytopenic purpura (TTP) | | 1 |
| Tricuspid atresia | | 1 |
| Tuberous sclerosis | TSC2 (2) | 3 |
| Ventricular tachycardia | | 5 |
| Vertebrobasilar insufficiency(VBI) | | 1 |
| Vici syndrome (VICIS) | EPG5 (1) | 1 |
| Werner syndrome | | 1 |
| West syndrome | | 1 |
| Wilson’s disease | | 4 |
| Wolfram syndrome | | 1 |
| Wolman disease | | 1 |
| X-linked creatine transporter deficiency | | 1 |
| X-linked dystonia Parkinsonism | TAF1 VARIANT (34) | 34 |
| Xeroderma pigmentosum | | 2 |
